BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Young Innovations, Inc. (YDNT) Announces Record Sales and EPS for the Nine-Months Ended September 30, 2012 and Declares Quarterly Dividend


10/24/2012 10:17:15 AM

ST. LOUIS, Oct. 23, 2012 /PRNewswire/ -- Young Innovations, Inc. (NASDAQ – YDNT) today announced record sales and earnings per share for the nine-months ended September 30, 2012.Sales for the third quarter of 2012 were $27.1 million, an increase of 3.5% from the $26.2 million reported for the third quarter of 2011. Income from operations for the third quarter increased 6.0% to $6.6 million from $6.3 million in the prior year quarter. Net income for the third quarter increased 4.8% to $4.3 million from $4.1 million in the third quarter of 2011. Diluted earnings per share for the third quarter of 2012 were $0.54, an increase of 5.9% over the $0.51 reported in the prior year quarter. Diluted earnings per share were affected by equity compensation expense of $0.04 in both the third quarter of 2012 and 2011. Diluted shares outstanding were 7.9 million for the third quarter of 2012, down 1.6% from 8.0 million in the prior year quarter.

Read at Yahoo Finance

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES